Leadership & Pay ·
Estrella Immunopharma appoints Cynthia Pussinen as CEO and Chairperson; Cheng Liu steps down
ESLAEstrella Immunopharma, Inc.
On October 25, 2026, Estrella Immunopharma appointed Cynthia Pussinen as Chief Executive Officer, Class I director, and Chairperson of the Board. She receives a $250,000 base salary with automatic increases tied to funding milestones and a 1,000,000-share option grant. Cheng Liu ceased serving as CEO, remaining as President and Chief Scientific Officer. The company also proposed eliminating its authority to leave director classes unoccupied, aiming for equal class sizes by 2027. Estrella Immunopharma operates in the biotechnology industry, focusing on immunotherapy treatments.